Viking Therapeutics Inc.
VKTX | NASDAQ
$30.11
+$1.12 (+3.86%)
At close: Sep 21, 2026, 4:00 PM ET
$32
+$1.89 (+6.28%)
Pre-market:
Sep 22, 2026, 4:21 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 94K | 114K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | -94K | -114K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -132.6M | -164.13M | -164.74M | -98.56M | -74.57M | -55.47M | -46.24M | -36.56M | -34.05M | -34.07M | -29.29M | -27.27M | -23.74M | -20.54M | -20.28M | -16.2M | -17.63M | -16.25M | -12.51M | -13.4M | -15.54M | -14.23M |
Interest Income | 4.55M | 5.8M | 7.04M | 7.77M | 9.03M | 9.86M | 10.84M | 11.53M | 11.82M | 6.75M | 4.71M | 4.73M | 4.55M | 1.03M | 732K | 450K | 253K | 154K | 159K | 125K | 181K | 239K |
Pretax Income | -128.02M | -158.33M | -157.66M | -90.79M | -65.56M | -45.63M | -35.42M | -24.94M | -22.25M | -27.36M | -24.61M | -22.53M | -19.23M | -19.53M | -19.56M | -15.77M | -17.43M | -16.1M | -12.36M | -13.24M | -15.38M | -14.01M |
Net Income | -128.02M | -158.33M | -157.66M | -90.79M | -65.56M | -45.63M | -35.42M | -24.94M | -22.25M | -27.36M | -24.61M | -22.53M | -19.23M | -19.53M | -19.56M | -15.77M | -17.43M | -16.1M | -12.36M | -13.24M | -15.38M | -14.01M |
Selling & General & Admin | 16.84M | 13.98M | 11.28M | 8.61M | 14.42M | 14.08M | 15.25M | 13.77M | 10.29M | 9.97M | 8.78M | 8.89M | 9.82M | 9.53M | 4.11M | 4.24M | 4.09M | 3.69M | 2.66M | 2.61M | 2.74M | 2.69M |
Research & Development | 115.75M | 150.15M | 153.46M | 89.95M | 60.15M | 41.39M | 30.99M | 22.79M | 23.77M | 24.1M | 20.5M | 18.38M | 13.92M | 11.01M | 16.18M | 11.96M | 13.54M | 12.56M | 9.85M | 10.8M | 12.8M | 11.54M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 132.6M | 164.13M | 164.74M | 98.56M | 74.57M | 55.47M | 46.24M | 36.56M | 34.05M | 34.07M | 29.29M | 27.27M | 23.74M | 20.54M | 20.28M | 16.2M | 17.63M | 16.25M | 12.51M | 13.4M | 15.54M | 14.23M |
Interest Expense | n/a | n/a | n/a | 8K | 24K | 24K | 24K | 24K | 18K | 28K | 26K | 2K | 32K | 28K | 8K | 27K | 12K | n/a | 12K | n/a | 21K | 21K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 132.6M | 164.13M | 164.74M | 98.56M | 74.57M | 55.47M | 46.24M | 36.56M | 34.05M | 34.07M | 29.29M | 27.27M | 23.74M | 20.54M | 20.28M | 16.2M | 17.63M | 16.25M | 12.51M | 13.4M | 15.54M | 14.23M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 115.92M | 115.57M | 114.01M | 112.32M | 112.13M | 112.07M | 111.34M | 110.91M | 110.39M | 103.46M | 100.11M | 99.85M | 99.01M | 78.35M | 76.59M | 76.51M | 77.03M | 77.41M | 76.91M | 78.01M | 77.9M | 74.78M |
Shares Outstanding (Diluted) | 115.92M | 115.57M | 114.01M | 112.32M | 112.13M | 112.07M | 111.34M | 110.91M | 110.39M | 103.46M | 100.11M | 99.85M | 99.01M | 78.35M | 76.59M | 76.51M | 77.03M | 77.41M | 76.91M | 78.01M | 77.9M | 74.78M |
EPS (Basic) | -1.10 | -1.37 | -1.38 | -0.81 | -0.58 | -0.41 | -0.32 | -0.22 | -0.20 | -0.26 | -0.25 | -0.23 | -0.19 | -0.24 | -0.25 | -0.20 | -0.23 | -0.21 | -0.16 | -0.17 | -0.20 | -0.19 |
EPS (Diluted) | -1.10 | -1.37 | -1.38 | -0.81 | -0.58 | -0.41 | -0.32 | -0.22 | -0.20 | -0.26 | -0.25 | -0.23 | -0.19 | -0.24 | -0.25 | -0.20 | -0.23 | -0.21 | -0.16 | -0.17 | -0.20 | -0.19 |
EBITDA | -127.87M | -158.33M | -157.57M | -90.67M | -65.43M | -45.49M | -35.28M | -24.83M | -22.16M | -27.25M | -24.51M | -22.46M | -19.12M | -19.43M | -19.48M | -15.6M | -17.42M | -16.03M | -12.27M | -13.17M | -15.29M | -14.16M |
EBIT | -128.02M | -158.33M | -157.66M | -90.78M | -65.54M | -45.61M | -35.39M | -24.92M | -22.23M | -27.33M | -24.58M | -22.53M | -19.19M | -19.5M | -19.55M | -15.75M | -17.42M | -16.1M | -12.34M | -13.24M | -15.36M | -14.23M |
Depreciation & Amortization | 157K | n/a | 94K | 114K | 112K | 111K | 110K | 87K | 75K | 74K | 74K | 73K | 73K | 72K | 72K | 142K | n/a | 77K | 76K | 75K | 73K | 72K |
Add to Watchlist
Select watchlists to add or remove VKTX